Cannabis

Canna Law Blog: The Isle Of Man Looks To Become A Medical Cannabis Hub September 27, 2021

September 2021 - Cannabis

by AlphaMaven

To see the entire post click here.

Last year, the Isle of Man’s parliament (Tynwald) amended the Misuse of Drugs Act 1976, in order to provide a legal framework for the development of a cannabis industry on the island. Specifically, the Act now allows the Gambling Supervision Commission (GSC) to except cannabinol, cannabinol derivatives, cannabis, or cannabis resin (other than a medical cannabis product) from the Act’s general prohibitions on the importation, exportation, production, supply or offer to supply, and possession of controlled drugs. Medical cannabis products may be excepted as well, provided the GSC obtains the consent of the Department of Health and Social Care (DHSC).

To see the entire post click here.

Send The Author A Message

Send Message

Access Over 250K+ Industry Headlines, Posts and Updates

You May Also Enjoy The Following Posts

Andrea Alms Video: Money In Motion 141 - JP Morgan Healthcare Conference 2025
1mo ago PrivateEquity BrookDell Partners

Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants

Easily Customize Content to Match Your Investment Preferences
Breaking News 24/7/365
Daily Newsletter & Indices
Alternative Investment Listings & LeaderBoards
Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
Company Directory
Contact Directory
Member Posts & Publications
Alpha University Video Series to Expand Investor Knowledge
AUM Accelerator Program (designed for investment managers)
Over 450K+ Industry Headlines, Posts and Updates

ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.